These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 2572282
21. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus. Mansuri MM, Hitchcock MJ, Buroker RA, Bregman CL, Ghazzouli I, Desiderio JV, Starrett JE, Sterzycki RZ, Martin JC. Antimicrob Agents Chemother; 1990 Apr; 34(4):637-41. PubMed ID: 1693057 [Abstract] [Full Text] [Related]
22. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis. Scheding S, Media JE, Nakeff A. Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060 [Abstract] [Full Text] [Related]
23. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. Br J Haematol; 1988 Jul; 69(3):299-304. PubMed ID: 3261597 [Abstract] [Full Text] [Related]
24. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice. Prakash O, Rodriguez VE, Tang ZY, Zhou P, Coleman R, Dhillon G, Shellito JE, Nelson S. Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858 [Abstract] [Full Text] [Related]
25. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Daluge SM, Purifoy DJ, Savina PM, St Clair MH, Parry NR, Dev IK, Novak P, Ayers KM, Reardon JE, Roberts GB. Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782 [Abstract] [Full Text] [Related]
26. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Balzarini J, Cooney DA, Dalal M, Kang GJ, Cupp JE, DeClercq E, Broder S, Johns DG. Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994 [Abstract] [Full Text] [Related]
27. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells. Dornsife RE, St Clair MH, Huang AT, Panella TJ, Koszalka GW, Burns CL, Averett DR. Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977 [Abstract] [Full Text] [Related]
28. Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis. Peterson AR, Danenberg PV, Ibric LL, Peterson H. Basic Life Sci; 1985 Feb; 31():313-34. PubMed ID: 3158302 [Abstract] [Full Text] [Related]
29. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Darnowski JW, Goulette FA. Biochem Pharmacol; 1994 Nov 01; 48(9):1797-805. PubMed ID: 7980649 [Abstract] [Full Text] [Related]
37. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H. Proc Natl Acad Sci U S A; 1986 Nov 01; 83(21):8333-7. PubMed ID: 2430286 [Abstract] [Full Text] [Related]
38. Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine. Medina DJ, Tung PP, Lerner-Tung MB, Nelson CJ, Mellors JW, Strair RK. J Virol; 1995 Mar 01; 69(3):1606-11. PubMed ID: 7853495 [Abstract] [Full Text] [Related]
39. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. Tosi P, Calabresi P, Goulette FA, Renaud CA, Darnowski JW. Cancer Res; 1992 Aug 01; 52(15):4069-73. PubMed ID: 1638518 [Abstract] [Full Text] [Related]
40. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture. Grant S, Bhalla K, Arlin Z, Howe CW. Exp Hematol; 1990 Jan 01; 18(1):41-8. PubMed ID: 2298268 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]